Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
By P. Okin, R. Devereux, S. Jern, S. Kjeldsen, S. Julius, M. Nieminen, S. Snapinn, Katherine E. Harris, P. Aurup, J. Edelman and 3 more. Journal of the American Medical Association (JAMA), 2004
620 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/42cec127fa66f793fdc9dc96f53af61adf031d31
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, methodology): “Electrocardiography can also be used to detect patterns of ventricular overload or ‘strain’, which indicates more severe risk [149,150,152], ischaemia, conduction abnormalities, left atrial dilatation and arrhythmias, including atrial fibrillation.”
- ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “Accordingly, the ECG is valuable, at least in patients over 55 years of age.(150,151) Electrocardiography can also be used to detect patterns of ventricular overload or ‘strain’, which indicates more severe risk,(149,150,152) ischaemia, conduction abnormalities, left atrial dilatation and arrhythmia”
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “ECG LVH can be used as a tool documenting LVH regression, possibly associated with a reduced incidence of new-onset AF.(419) A recent prospective study focused on the R-wave voltage in the aVL lead as a prognostic sign in hypertensive patients without ECG LVH.”